Yogi Hendlin, PhD

Title(s)Research Associate, Ob/Gyn, Reproductive Sciences
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, CaliforniaPostdoctoral Research Fellow2018Tobacco Control, Public Health
    University of Vienna, AustriaPostdoctoral Research Fellow2015Plant Ethics
    University of Kiel, GermanyPhD2015Environmental Philosophy
    University of California, Los Angeles, CaliforniaMA2012Political Science
    London School of Economics, UKMSc2005Political Theory
    University of California, Berkeley, CaliforniaBA, BA2003Rhetoric; Political Science

    Collapse Overview 
    Collapse Overview
    Yogi Hale Hendlin, PhD is a Research Associate at the Environmental Health Initiative focusing on the corporate determinants of health vis-à-vis the impacts of the chemical and fossil fuel industries. Working in industry documents research since 2006, initially focusing on the tobacco industry, Hendlin applies documents research to the issues of environmental justice, conflicts of interest in science, and regulation.

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hendlin YH, Vora M, Elias J, Ling PM. Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review. Am J Public Health. 2019 Jul; 109(7):e1-e8. PMID: 31095414.
      View in: PubMed
    2. Hendlin YH, Bialous SA. The environmental externalities of tobacco manufacturing: A review of tobacco industry reporting. Ambio. 2019 Mar 09. PMID: 30852780.
      View in: PubMed
    3. Hendlin YH. I am a fake loop: The effects of advertising-based artificial selection. Biosemiotics. 2019 Apr; 12(1):131-156. PMID: 31217829.
      View in: PubMed
    4. Hendlin YH. Alert: Public Health Implications of Electronic Cigarette Waste. Am J Public Health. 2018 Nov; 108(11):1489-1490. PMID: 30303735.
      View in: PubMed
    5. Elias J, Hendlin YH, Ling PM. Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents. PLoS Med. 2018 05; 15(5):e1002562. PMID: 29715300.
      View in: PubMed
    6. Hendlin YH, Veffer JR, Lewis MJ, Ling PM. Beyond the brotherhood: Skoal Bandits' role in the evolution of marketing moist smokeless tobacco pouches. Tob Induc Dis. 2017; 15:46. PMID: 29270101.
      View in: PubMed
    7. Hendlin YH, Elias J, Ling PM. The Pharmaceuticalization of the Tobacco Industry. Ann Intern Med. 2017 08 15; 167(4):278-280. PMID: 28715843.
      View in: PubMed
    8. Elias J, Hendlin Y, Chaffee BW, Ling PM. Don't throw smokeless tobacco users under the bus. Addict Behav. 2018 02; 77:289-290. PMID: 28410775.
      View in: PubMed
    9. Kennedy A, Sullivan S, Hendlin Y, Barnes R, Glantz S. Strong tobacco control program requirements and secure funding are not enough: lessons from Florida. Am J Public Health. 2012 May; 102(5):807-17. PMID: 22420813; PMCID: PMC3325324.
    10. Hendlin Y, Anderson SJ, Glantz SA. 'Acceptable rebellion': marketing hipster aesthetics to sell Camel cigarettes in the US. Tob Control. 2010 Jun; 19(3):213-22. PMID: 20501494; PMCID: PMC3088012.
    11. Tung GJ, Hendlin YH, Glantz SA. Competing initiatives: a new tobacco industry strategy to oppose statewide clean indoor air ballot measures. Am J Public Health. 2009 Mar; 99(3):430-9. PMID: 19150904; PMCID: PMC2642532.